FDA Workshop To Consider Pediatric Research Rules Compliance By OTCs Available Through NDAs

NDAs for additional OTC products containing acetaminophen and/or NSAIDs and indicated for use by children between 2 and less than 12 years old would trigger compliance by application sponsors with the act passed in 2003 to address lack of pediatric use information in drug labeling.